Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
alginate nanoparticles as anti tuberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential
Your search for
Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potentia
retrieved no results
Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
Indian J Chest Dis Allied Sci. 2006 Jul-Sep;48(3):171-6.
Indian J Chest Dis Allied Sci. 2006.
PMID: 18610673
RESULTS: High drug encapsulation efficiency was achieved in alginate nanoparticles, ranging from 70%-90%. ...CONCLUSIONS: Alginate nanoparticles appear to have the potential for intermittent therapy of TB....
RESULTS: High drug encapsulation efficiency was achieved in alginate nanoparticles, ranging from 70%-90%. ...CONCLUSION …
Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K, Dwivedi H.
Kushwaha K, et al.
Pharm Nanotechnol. 2018;6(3):209-217. doi: 10.2174/2211738506666180625120038.
Pharm Nanotechnol. 2018.
PMID: 29938624
METHOD: The formulations were based on 32 factorial designs. Nanoparticles of combined drug (Isoniazid- INH and Pyrazinamide-PYZ) were fabricated using natural polymer. ...CONCLUSION: It concluded that chitosan (CS) and sodium alginate (AL) concentrati …
METHOD: The formulations were based on 32 factorial designs. Nanoparticles of combined drug (Isoniazid- INH and Pyrazin …
Item in Clipboard
Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis.
Scolari IR, Páez PL, Sánchez-Borzone ME, Granero GE.
Scolari IR, et al.
AAPS PharmSciTech. 2019 Jan 9;20(2):67. doi: 10.1208/s12249-018-1278-7.
AAPS PharmSciTech. 2019.
PMID: 30627867
The aim of this study was to design a nanocarrier system for inhalation delivery of rifampicin (RIF) in combination with ascorbic acid (ASC), namely constituted of sodium alginate coated with chitosan and Tween 80 (RIF/ASC NPs) as a platform for the treatment of pul …
The aim of this study was to design a nanocarrier system for inhalation delivery of rifampicin (RIF) in combination with ascorbic acid …
Item in Clipboard
Cite
Cite